PHASE-II STUDY OF RECOMBINANT ALPHA-2 INTERFERON IN RESISTANT MULTIPLE-MYELOMA

被引：99

作者：

COSTANZI, JJ

COOPER, MR

SCARFFE, JH

OZER, H

GRUBBS, SS

FERRARESI, RW

POLLARD, RB

SPIEGEL, RJ

机构：

[1] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, WINSTON SALEM, NC 27103 USA

[2] UNIV MANCHESTER, MANCHESTER M13 9PL, LANCS, ENGLAND

[3] NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, CTR CANC, BUFFALO, NY 14263 USA

[4] DARTMOUTH COLL, HITCHCOCK MED CTR, HANOVER, NH 03756 USA

[5] SCHERING CORP, KENILWORTH, NJ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1985年 / 3卷 / 05期

关键词：

D O I：

10.1200/JCO.1985.3.5.654

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：654 / 659

页数：6

共 25 条

[1]

AAPRO MS, 1983, CANCER CHEMOTH PHARM, V10, P161

[2]

ALEXANIAN R, 1982, CLIN HAEMATOL, V11, P211

[3] ANALYSIS OF SURVIVAL BY TUMOR RESPONSE [J].

ANDERSON, JR ;

CAIN, KC ;

GELBER, RD .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) :710-719

[4]

BENNETT JM, 1978, CANCER TREAT REP, V62, P1367

[5] PROGRESS IN THE TREATMENT OF PLASMA-CELL MYELOMA [J].

BERGSAGEL, D .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (08) :510-512

[6]

BERGSAGEL DE, 1972, CAN MED ASSOC J, V107, P851

[7]

BERGSAGEL DE, 1962, CANCER CHEMOTH REP, P87

[8]

BLADE J, 1983, CANCER, V52, P786, DOI 10.1002/1097-0142(19830901)52:5<786::AID-CNCR2820520505>3.0.CO

[9]

2-H

[10]

COHEN JH, 1972, AM J CLIN ONCOL-CANC, V5, P21

← 1 2 3 →